Get A Drip, a UK-based health and wellness company, has announced it is among the first providers to offer the newly approved oral formulation of Wegovy (semaglutide) in the United Kingdom. The oral version, which received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) earlier this year, provides an alternative to the injectable form for weight management.
The company stated that the oral Wegovy will be available through its online platform, allowing patients to access the medication after a consultation with a healthcare professional. This move aims to increase accessibility for individuals seeking treatment for obesity or weight-related conditions.
Wegovy, originally developed by Novo Nordisk, has been shown in clinical trials to aid significant weight loss when combined with diet and exercise. The oral formulation is expected to offer similar efficacy with the convenience of a daily pill, potentially reducing barriers for patients who are hesitant about injections.
Health experts have welcomed the availability of oral Wegovy, noting that it could expand treatment options for the millions of UK adults living with obesity. However, they emphasize that the medication should be used under medical supervision and as part of a comprehensive weight management plan.
